Plantinga Laura C, Patzer Rachel E, Drenkard Cristina, Kramer Michael R, Klein Mitchel, Lim S Sam, McClellan William M, Pastan Stephen O
Rollins School of Public Health and Laney Graduate School, Emory University, Atlanta, Georgia.
Arthritis Care Res (Hoboken). 2015 Apr;67(4):571-81. doi: 10.1002/acr.22482.
Providers recommend waiting to transplant patients with end-stage renal disease (ESRD) secondary to lupus nephritis (LN), to allow for quiescence of systemic lupus erythematosus (SLE)-related immune activity. However, these recommendations are not standardized, and we sought to examine whether duration of time to transplant was associated with risk of graft failure in US LN-ESRD patients.
Using national ESRD surveillance data (United States Renal Data System), we identified 4,743 US patients with LN-ESRD who received a first transplant on or after January 1, 2000 (followup through September 30, 2011). The association of wait time (time from ESRD start to transplant) with graft failure was assessed with Cox proportional hazards models, with splines of the exposure to allow for nonlinearity of the association and with adjustment for potential confounding by demographic, clinical, and transplant factors.
White LN-ESRD patients who were transplanted later (versus at <3 months receiving dialysis) were at increased risk of graft failure (3-12 months: adjusted hazard ratio [HR] 1.23, 95% confidence interval [95% CI] 0.93-1.63; 12-24 months: adjusted HR 1.37, 95% CI 0.92-2.06; 24-36 months: adjusted HR 1.34, 95% CI 0.92-1.97; and >36 months: adjusted HR 1.98, 95% CI 1.31-2.99). However, no such association was seen among African American recipients (3-12 months: adjusted HR 1.07, 95% CI 0.79-1.45; 12-24 months: adjusted HR 1.01, 95% CI 0.64-1.60; 24-36 months: adjusted HR 0.78, 95% CI 0.51-1.18; and >36 months: adjusted HR 0.74, 95% CI 0.48-1.13).
While future studies are needed to examine the potential confounding effect of clinically recognized SLE activity on the observed associations, these results suggest that longer wait times to transplant may be associated with equivalent or worse, not better, graft outcomes among LN-ESRD patients.
医疗服务提供者建议等待狼疮性肾炎(LN)继发的终末期肾病(ESRD)患者进行移植,以使系统性红斑狼疮(SLE)相关的免疫活动静止。然而,这些建议并不标准化,我们试图研究在美国LN-ESRD患者中,移植等待时间是否与移植失败风险相关。
利用国家ESRD监测数据(美国肾脏数据系统),我们确定了4743例2000年1月1日或之后接受首次移植的美国LN-ESRD患者(随访至2011年9月30日)。采用Cox比例风险模型评估等待时间(从ESRD开始至移植的时间)与移植失败的关联,使用暴露变量的样条函数以考虑关联的非线性,并对人口统计学、临床和移植因素的潜在混杂因素进行调整。
移植时间较晚的白人LN-ESRD患者(与透析<3个月时移植相比)移植失败风险增加(3 - 12个月:调整后风险比[HR] 1.23,95%置信区间[95%CI] 0.93 - 1.63;12 - 24个月:调整后HR 1.37,95%CI 0.92 - 2.06;24 - 36个月:调整后HR 1.34,95%CI 0.92 - 1.97;>36个月:调整后HR 1.98,95%CI 1.31 - 2.99)。然而,在非裔美国受者中未观察到这种关联(3 - 12个月:调整后HR 1.07,95%CI 0.79 - 1.45;12 - 24个月:调整后HR 1.01,95%CI 0.64 - 1.60;24 - 36个月:调整后HR 0.78,95%CI 0.51 - 1.18;>36个月:调整后HR 0.74,95%CI 0.48 - 1.13)。
虽然需要进一步研究来检验临床认可的SLE活动对观察到的关联的潜在混杂效应,但这些结果表明,在LN-ESRD患者中,较长的移植等待时间可能与移植结局相同或更差,而非更好相关。